BioCentury
ARTICLE | Financial News

C-Bridge leads Nuance's series B

June 28, 2018 9:19 PM UTC

Nuance Biotech (Shanghai) Co. Ltd. (Shanghai, China) raised $20 million in a series B round led by C-Bridge Capital. Nuance is eligible to receive an additional $15 million from C-Bridge for acquiring new products.

Nuance has a portfolio of in-licensed assets that are already marketed or under review with China's State Drug Administration, as well as products in clinical development...